Verastem Inc (NASDAQ:VSTM)
| 1.44 Delayed Data As of 4:00pm ET |  +0.015 / +1.06%Today’s Change | 1.34 Today|||52-Week Range 4.93 | -30.00% Year-to-Date |
Latest VSTM News | Press Releases
No recent news for Verastem Inc.
Today’s Trading
| Previous close | 1.42 |
| Today’s open | 1.41 |
| Day’s range | 1.34 - 1.44 |
| Volume | 65,041 |
| Average volume (3 months) | 1,752,432 |
| Market cap | $278.7M |
Data as of 4:00pm ET, 01/28/2022
Growth & Valuation
| Earnings growth (last year) | +77.92% |
| Earnings growth (this year) | +6.82% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +6.07% |
| P/E ratio | NM |
| Price/Sales | 17.64 |
| Price/Book | 2.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DTILPrecision BioScience... | +0.10 | +2.35% |
| ALTAltimmune Inc | +0.70 | +10.72% |
| SELBSelecta Biosciences ... | +0.12 | +5.36% |
| CUECue Biopharma Inc | -0.77 | -9.64% |
Data as of 4:00pm ET, 01/28/2022
Financials
| Next reporting date | March 15, 2022 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $18.5M |
| Annual profit (last year) | -$67.7M |
| Net profit margin | -365.77% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Needham, Massachusetts |
Forecasts
